View Older Stories View More Recent Stories

Oct 7, 2019 04:11PM Qiagen (QGEN) sees Q3 preliminary total net sales growth of about 3%
Oct 7, 2019 04:09PM Qiagen (QGEN) CEO and Chairman Peer M. Schatz to Step Down
Oct 7, 2019 04:07PM QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests
Oct 7, 2019 04:07PM QIAGEN Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation
Oct 7, 2019 04:07PM QIAGEN Announces CEO Leadership Transition
Oct 7, 2019 04:06PM Illumina (ILMN), QIAGEN (QGEN) Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests
Oct 7, 2019 04:05PM Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests
Sep 10, 2019 01:30AM QIAGEN Announces Change in Global Sales Structure
Jul 30, 2019 04:05PM QIAGEN reports full results for second quarter and first half of 2019
Jul 24, 2019 04:09PM QIAGEN Reports Results for Second Quarter of 2019; Updates Full-Year 2019 Outlook Due to Decision to Restructure China NGS Partnership
Apr 11, 2019 04:02PM QIAGEN’s QuantiFERON®-TB Passes Milestone of 60 Million Tests in Global Fight against Tuberculosis, Current Annual Run Rate Exceeds 12 Million Tests
Apr 11, 2019 04:01PM QIAGEN and NeuMoDx expand assay menu for their next generation of fully integrated PCR systems for clinical laboratories in Europe and also announce availability of NeuMoDx 96 version
Apr 11, 2019 04:00PM QIAGEN Highlights Profile of New QIAstat-Dx Meningitis / Encephalitis pAnel Focused on Most Prevalent Central Nervous System Pathogens
May 2, 2018 04:06PM QIAGEN Reports Results for First Quarter 2018
Mar 12, 2018 04:29PM QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN's GeneReader NGS System
Nov 6, 2017 04:05PM QIAGEN Reports Results for Third Quarter and First Nine Months of 2017
Jul 27, 2017 11:16AM QIAGEN Reports Results for Second Quarter and First Half of 2017
Jun 3, 2017 01:00PM Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies
May 2, 2017 04:05PM QIAGEN Reports Results for First Quarter 2017
Feb 1, 2017 04:05PM QIAGEN Reports Results for Fourth Quarter and Full-year 2016
Nov 16, 2016 08:34AM HTG Molecular Diagnostics (HTGM), QIAGEN (QGEN) Unit to Develop NGS-Based Diagnostics Solution
Nov 16, 2016 08:30AM HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics
Nov 2, 2016 04:03PM QIAGEN Reports Results for Third Quarter and First Nine Months of 2016
Oct 20, 2016 04:08PM Qiagen (QGEN) Announces Launch of QIAscout
Oct 20, 2016 04:05PM QIAGEN Launches QIAscout for Single-cell Isolation
Oct 17, 2016 04:05PM QIAGEN Unveils Unique Sample to Insight Solutions for Liquid Biopsies and Hereditary Diseases
Oct 10, 2016 04:05PM QIAGEN Launches High-throughput Solutions for Human ID Databases
Sep 12, 2016 06:17AM Qiagen (QGEN) Receives Unfavorable Decision in '537 Patent Suit
Sep 10, 2016 11:30AM QIAGEN Comments on Preliminary Injunction and Confirms Intention to Defend its U.S. Intellectual Property Position
Sep 8, 2016 12:46PM QIAGEN Welcomes U.S. Guidance for Latent TB Testing in Primary Care
Aug 15, 2016 06:11AM Qiagen (QGEN) Plans to Return $250M to Shareholders Through Synthetic Buyback Program
Aug 14, 2016 08:48AM QIAGEN Announces Plans to Return Approximately $250 Million to Shareholders Via Synthetic Share Repurchase Proposal
Jul 28, 2016 04:05PM QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-2017
Jul 27, 2016 04:07PM QIAGEN Launches "Digital NGS" Solutions with Unique Molecular Index Technology to Reliably Detect All Genetic Variation
Jul 27, 2016 04:05PM QIAGEN Launches Novel Integrated System for Collection, Stabilization, Transport, Storage and Isolation of Circulating Cell-free DNA
Jun 23, 2016 06:10AM Qiagen (QGEN) Completes Exiqon Tender Offer
Jun 23, 2016 05:45AM QIAGEN Announces Successful Completion of Tender Offer for Shares in Exiqon
Jun 21, 2016 07:49AM QIAGEN Joins Consortium to Map Microbial Genomes in 54 Cities
Jun 14, 2016 04:05PM QIAGEN Launches QIAsure Methylation Test to Determine Cervical Cancer Risk
Jun 8, 2016 10:18AM Qiagen (QGEN) Reduces Offer Threshold for Acquisition of Exiqon A/S Shares
Jun 8, 2016 10:13AM QIAGEN Changes Offer Conditions for Acquisition of Shares in Exiqon A/S
Jun 2, 2016 04:05PM QIAGEN Forms Lung Cancer Expert Alliance
Jun 1, 2016 04:05PM QIAGEN Launches Liquid Biopsy Workflow for GeneReader NGS System
May 31, 2016 04:05PM QIAGEN Integrates Quality Control Tools into GeneReader NGS System
May 25, 2016 04:05PM QIAGEN Partners to Develop Predictive Tests in Oncology
May 19, 2016 10:30AM QIAGEN Extends Tender Offer Period for Acquisition of Exiqon A/S
Apr 27, 2016 04:13PM QIAGEN Reports Results for First Quarter of 2016
Apr 19, 2016 02:50AM QIAGEN Publishes Offer Document in Connection with the Conditional Voluntary Takeover Offer for the Shares in Exiqon A/S
Apr 14, 2016 04:05PM QIAGEN Launches Streamlined Bioinformatics for RNA Sequencing of Liquid Biopsies
Apr 13, 2016 04:13PM Qiagen (QGEN), Mirati Therapeutics (MRTX) to Collaborate on Diagnostic in Lung Cancer
View More Recent Stories View Older Stories